Lunch & Learn: JPM Founders Roundtable

Event Description

J.P. Morgan Annual Healthcare Conference (JPM 2025) will take place January 13–16, 2025 in San Francisco, CA. It is the largest healthcare investment symposium, bringing together investors, industry leaders, and innovative tech creators.

Attendance is by invitation only. However, founders can still take advantage of the convergence of investors on the Bay Area at a variety of events and parties adjacent to the conference during the week. Additionally, it is the perfect time to schedule meetings.

Get hot tips - like how Daybreak Labs members can take advantage of their Biocom membership to have space in San Francisco during JPM 2025 week for meetings - and more from Daybreak Labs Advisors, Janelle Muranaka and Reem Mahrat, in this informal discussion. Start with questions, leave with a strategy!

About Reem Mahrat
Reem Mahrat is a Daybreak Labs Advisor to Therapeutics and Diagnostic companies and Entrepreneur in Residence. As co-founder and CEO of EGE and EazeBio, and past CEO and co-founder of Raman ID, a biotechnology company that develops innovative solutions for precision medicine, Reem has lead a team of talented scientists and engineers who are passionate about transforming healthcare to a successful acquisition.

With over 20 years of experience in the life sciences industry, Reem co-founded and managed multiple ventures, such as Calico Bio Labs and Verano Bioscience, that have delivered cutting-edge products and services for various applications, such as stem cell research, cancer diagnostics, and drug discovery.

Reem contributes to the advancement of the biotechnology field through involvement in the American Association for Precision Medicine, the CEO Clubs Network, and Together Women Rise. Committed to helping startups succeed in the Tri-Valley, Reem serves as a Daybreak Labs advisor for early stage diagnostics and therapeutics companies. 

About Janelle Muranaka

Daybreak Labs operations advisor Janelle Muranaka is an accomplished Executive with a proven track record of scaling biotechnology startups from seed funding through clinical development. Combining technical expertise in cell and molecular biology, vaccine development, and protein engineering with strong leadership, Janelle has built operational frameworks that drive growth and innovation. She also now serves on the Advisory Board, as Head of Business Development at EazeBio, a Daybreak Labs company.
Key achievements include scaling Meissa Vaccines through Phase I clinical trials, founding Maxygen LLC to deliver advanced protein optimization services, and transforming Altravax into a revenue-driven organization. Known for strategic planning, team building, and fostering cross-functional collaboration, Janelle ensures alignment between R&D and business operations to achieve ambitious corporate goals.
With a passion for cultivating efficiency and quality, Janelle is dedicated to advancing life sciences innovation through operational excellence and strategic leadership. Complementing her professional experience, Janelle is an active contributor to the life sciences community, where she volunteers as an advisor and an organizer for industry events and panels, sharing insights on scaling startups, operational strategy, and innovation in biotechnology.

Host or Publisher Daybreak Labs